Scope
Reference
C382225
Description
As part of a preliminary market engagement exercise, NHS Blood & Transplant (NHSBT) are seeking to engage with suppliers of nucleic acids including plasmid DNA; synthetically produced DNA and/or enzymatically produced DNA. The intended use of the nucleic acids by NHSBT includes: a) the GMP grade production of gene therapy vectors such as lentiviral, adeno-associated viral vectors and novel gene therapy vectors, for clinical trials and commercial production where applicable; b) gene therapy vectors suitable for pre-clinical studies, such as toxicology and biodistribution studies and gene therapy vectors suitable for R&D purposes.
Commercial tool
Establishes a framework
Total value (estimated)
- £7,200,000 excluding VAT
- £8,640,000 including VAT
Above the relevant threshold
Contract dates (estimated)
- 15 June 2026 to 14 June 2034
- 8 years
Main procurement category
Goods
CPV classifications
- 33698000 - Clinical products
Contract locations
- UKK11 - Bristol, City of
Engagement
Engagement deadline
12 September 2025
Engagement process description
NHSBT conducted initial market engagement for ' Supply of Viral Vector Plasmids', via issue of a PIN under the Procurement Contract Regulations (Notice Identifier: 2024/S 000-029545). NHSBT have since updated the requirement to include synthetically produced DNA and/or enzymatically produced DNA. Therefore NHSBT are looking to engage further with suppliers who may have been missed from the initial market engagement, due to synthetic plasmids not being included. If you are interested in taking part in the market engagement, please contact james.marshall2@nhsbt.nhs.uk by no later than 12:00 hrs (GMT) on 12/09/2025. Market engagement is likely to take place via video calls in September 2025. There is no guarantee that a formal procurement process will be launched as a result of this early market engagement exercise, nor that any contract(s) will be placed. No remuneration or compensation etc will be paid to organisations who take part in this early market engagement exercise. Suppliers should take part in this process only on the basis that they fully understand and accept this position.
Submission
Publication date of tender notice (estimated)
8 December 2025
Contracting authority
NHS Blood and Transplant
- Public Procurement Organisation Number: PDBY-6395-VWBP
500 North Bristol Park
Bristol
BS34 7QH
United Kingdom
Email: james.marshall2@nhsbt.nhs.uk
Website: https://www.nhsbt.nhs.uk/
Region: UKK12 - Bath and North East Somerset, North Somerset and South Gloucestershire
Organisation type: Public authority - central government